XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Share Activity
The Company’s RSU, RSA, and PSA activities and related information as of and for the three months ended March 31, 2023 were as follows (in millions, except per share amounts and years):
Outstanding RSUs, RSAs, and PSAs
Number of SharesWeighted Average
Grant Date Fair
Value per Share
Weighted Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
Balance as of December 31, 2022
20.2 $26.78 
Granted(*)
2.9 31.03 
Vested(1.9)26.57 
Canceled(0.9)25.83 
Balance as of March 31, 2023
20.3 $27.44 1.3$699.0 
________________________________
(*)    Includes 1.1 million service-based, 1.4 million performance-based, and 0.4 million market-based awards. The number of shares subject to performance-based and market-based conditions represents the aggregate maximum number of shares that may be issued pursuant to the award over its full term. The grant date fair value of RSUs and PSAs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.
Schedule of Employee Stock Purchases through ESPP
The following table summarizes employee stock purchases through the ESPP (in millions, except per share amounts):
Three Months Ended March 31,
20232022
Shares purchased1.3 1.4 
Average exercise price per share$23.44 $20.07 
Schedule of Employee Service Share-Based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and ESPP purchase rights was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):
Three Months Ended March 31,
20232022
Cost of revenues - Product$1.7 $1.4 
Cost of revenues - Service4.7 4.5 
Research and development25.7 16.6 
Sales and marketing18.6 12.5 
General and administrative10.2 10.2 
Total$60.9 $45.2 
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award
The following table summarizes share-based compensation expense by award type (in millions):
 Three Months Ended March 31,
 20232022
Stock options$0.8 $1.5 
RSUs, RSAs, and PSAs53.0 38.5 
ESPP purchase rights7.1 5.2 
Total$60.9 $45.2